After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Mersana Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Mersana Therapeutics Inc is $343.52M. A total of 1.32 million shares were traded on the day, compared to an average of 1.06M shares.
In the most recent transaction, Bala Mohan sold 1,884 shares of MRSN for 1.90 per share on Oct 28 ’24. After the transaction, the SVP, Chief Development Officer now owns 54,731 company shares. In a previous transaction on Oct 28 ’24, Bala, Mohan bought 1,884 shares at 2.04 per share.
Among the insiders who sold shares, DeSchuytner Brian disposed of 8,089 shares on Oct 02 ’24 at a per-share price of $2.00. This resulted in the SVP, COO & CFO holding 100,422 shares of MRSN after the transaction. In another insider transaction, DeSchuytner Brian sold 5,598 shares at $1.96 per share on Oct 03 ’24. Company shares held by the SVP, COO & CFO now total 94,824.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, MRSN has a high of $6.28 and a low of $1.22.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MRSN’s latest balance sheet shows that the firm has $177.95M in Cash & Short Term Investments as of fiscal 2021. There were $38.18M in debt and $47.52M in liabilities at the time. Its Book Value Per Share was $0.01, while its Total Shareholder’s Equity was $121.74M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRSN is Buy with a score of 4.60.
